至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection.

Nat Commun. 2018; 
SongPeixin,ZhengNan,LiuYong,TianChen,WuXilin,MaXiaohua,ChenDeyan,ZouXue,WangGuiyang,WangHuanru,ZhangYongyang,LuSufang,WuChao,WuZh
Products/Services Used Details Operation
Catalog Antibody Vero cells were stained with camel Gn-IgG positive serum at 1:500, followed by Alexa Fluor 488- conjugated rabbit anti-camelid VHH antibody (Genscript, China) at 1:1000。The cells were stained with camel GnIgG positive serum at 1:500, followed by Alexa Fluor 488-conjugated rabbit anticamelid VHH antibody (Genscript, China) at 1:1000. 50% FRNT values for each serum dilution were determined by Graphpad Prism 5 software (USA). Get A Quote

摘要

Severe Fever with Thrombocytopenia Syndrome (SFTS), an emerging infectious disease caused by a novel phlebovirus, is associated with high fatality. Therapeutic interventions are lacking and disease pathogenesis is yet to be fully elucidated. The anti-viral immune response has been reported, but humoral involvement in viral pathogenesis is poorly understood. Here we show defective serological responses to SFTSV is associated with disease fatality and a combination of B-cell and T-cell impairment contribute to disruption of anti-viral immunity. The serological profile in deceased patients is characterized by absence of specific IgG to viral nucleocapsid and glycoprotein due to failure of B-cell class switch... More

关键词